Select Medical (SEM) to Release Earnings on Thursday

Select Medical (NYSE:SEM) is anticipated to post its quarterly earnings results after the market closes on Thursday, February 20th. Analysts expect Select Medical to post earnings of $0.29 per share and revenue of $1.50 billion for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Select Medical Stock Performance

Shares of NYSE SEM opened at $19.15 on Wednesday. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a 50 day simple moving average of $19.16 and a 200-day simple moving average of $28.31. The company has a market cap of $2.48 billion, a PE ratio of 8.95, a P/E/G ratio of 0.65 and a beta of 1.45. Select Medical has a 12-month low of $18.02 and a 12-month high of $40.98.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. UBS Group reduced their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. StockNews.com cut Select Medical from a “buy” rating to a “hold” rating in a report on Thursday, February 13th. Finally, Royal Bank of Canada boosted their target price on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Select Medical currently has an average rating of “Hold” and a consensus price target of $39.50.

Insiders Place Their Bets

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the transaction, the vice president now directly owns 30,356 shares in the company, valued at $605,602.20. The trade was a 14.12 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the transaction, the director now owns 22,000 shares in the company, valued at approximately $463,980. This represents a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.